Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha}2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma (Q80820301)
Jump to navigation
Jump to search
scientific article published on 20 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha}2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma |
scientific article published on 20 August 2007 |
Statements
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha}2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma (English)
M Middleton
A Hauschild
D Thomson
R Anderson
S Burdette-Radoux